INDSWIFT LABORATORIES
Back to Balance Sheet
|
INDSWIFT LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹1.36 Cr | ₹4.24 Cr | ₹36 Cr | ₹40 Cr | ₹23 Cr |
What is the latest Contingent Liabilities ratio of INDSWIFT LABORATORIES ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹1.36 Cr |
Mar2023 | ₹4.24 Cr |
Mar2022 | ₹36 Cr |
Mar2021 | ₹40 Cr |
Mar2020 | ₹23 Cr |
How is Contingent Liabilities of INDSWIFT LABORATORIES Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹1.36 Cr | -68.05 | |
Mar2023 | ₹4.24 Cr | -88.11 | |
Mar2022 | ₹36 Cr | -11.00 | |
Mar2021 | ₹40 Cr | 75.55 | |
Mar2020 | ₹23 Cr | - |
Compare Contingent Liabilities of peers of INDSWIFT LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDSWIFT LABORATORIES | ₹745.7 Cr | -3.9% | -7.7% | -20.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹407,551.0 Cr | 0.4% | 1.8% | 4.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹175,704.0 Cr | -1.1% | 0.1% | 45.6% | Stock Analytics | |
CIPLA | ₹123,675.0 Cr | 3.8% | 1.2% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,925.0 Cr | 2.2% | 11.7% | 11.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹106,626.0 Cr | 1.4% | -3.3% | -7.2% | Stock Analytics |
INDSWIFT LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDSWIFT LABORATORIES | -3.9% |
-7.7% |
-20.5% |
SENSEX | -0.4% |
-1.6% |
1.3% |
You may also like the below Video Courses